Eterna Therapeutics Statistics
Total Valuation
ERNA has a market cap or net worth of $11.63 million. The enterprise value is $41.81 million.
| Market Cap | 11.63M |
| Enterprise Value | 41.81M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ERNA has 5.41 million shares outstanding. The number of shares has increased by 74.17% in one year.
| Shares Outstanding | 5.41M |
| Shares Change (YoY) | +74.17% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 39.31% |
| Owned by Institutions (%) | 16.19% |
| Float | 2.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 171.06 |
| Forward PS | n/a |
| PB Ratio | 5.21 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 614.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 18.74.
| Current Ratio | 1.46 |
| Quick Ratio | 1.84 |
| Debt / Equity | 18.74 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -34.29 |
Financial Efficiency
Return on equity (ROE) is -509.00% and return on invested capital (ROIC) is -48.71%.
| Return on Equity (ROE) | -509.00% |
| Return on Assets (ROA) | -53.10% |
| Return on Capital (ROIC) | -48.71% |
| Revenue Per Employee | $8,500 |
| Profits Per Employee | -$2.71M |
| Employee Count | 8 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.74% in the last 52 weeks. The beta is 8.16, so ERNA's price volatility has been higher than the market average.
| Beta (1Y) | 8.16 |
| 52-Week Price Change | -33.74% |
| 50-Day Moving Average | 2.03 |
| 200-Day Moving Average | 1.96 |
| Relative Strength Index (RSI) | 48.14 |
| Average Volume (30 Days) | 8,633 |
Short Selling Information
The latest short interest is 42,434, so 0.78% of the outstanding shares have been sold short.
| Short Interest | 42,434 |
| Short Previous Month | 33,629 |
| Short % of Shares Out | 0.78% |
| Short % of Float | 1.44% |
| Short Ratio (days to cover) | 3.23 |
Income Statement
In the last 12 months, ERNA had revenue of $68,000 and -$21.68 million in losses. Loss per share was -$4.08.
| Revenue | 68,000 |
| Gross Profit | -168,000 |
| Operating Income | -21.47M |
| Pretax Income | -21.67M |
| Net Income | -21.68M |
| EBITDA | -19.93M |
| EBIT | -21.06M |
| Loss Per Share | -$4.08 |
Balance Sheet
The company has $11.67 million in cash and $41.84 million in debt, giving a net cash position of -$30.17 million or -$5.58 per share.
| Cash & Cash Equivalents | 11.67M |
| Total Debt | 41.84M |
| Net Cash | -30.17M |
| Net Cash Per Share | -$5.58 |
| Equity / Book Value | 2.23M |
| Book Value Per Share | 0.41 |
| Working Capital | 3.03M |
Cash Flow
In the last 12 months, operating cash flow was -$20.41 million and capital expenditures -$19,000, giving a free cash flow of -$20.43 million.
| Operating Cash Flow | -20.41M |
| Capital Expenditures | -19,000 |
| Free Cash Flow | -20.43M |
| FCF Per Share | -$3.84 |
Margins
Gross margin is -247.06%, with operating and profit margins of -31,572.06% and -31,888.24%.
| Gross Margin | -247.06% |
| Operating Margin | -31,572.06% |
| Pretax Margin | -31,869.12% |
| Profit Margin | -31,888.24% |
| EBITDA Margin | -29,314.71% |
| EBIT Margin | -30,966.18% |
| FCF Margin | -30,039.71% |
Dividends & Yields
ERNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -74.17% |
| Shareholder Yield | -74.17% |
| Earnings Yield | -186.41% |
| FCF Yield | -175.61% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 17, 2022. It was a reverse split with a ratio of 1:20.
| Last Split Date | Oct 17, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
ERNA has an Altman Z-Score of -6.52 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.52 |
| Piotroski F-Score | 1 |